Joshua L. Lachowicz

An orally bioavailable parthenolide analog selectively eradicates acute myelogenous leukemia stem and progenitor cells

Mónica L. Guzmán, Randall M. Rossi, Sundar Neelakantan et al. · Blood · 2007 · 407 citations · Full text

Intratumoral injection of <i>Clostridium novyi</i> -NT spores induces antitumor responses

Nicholas J. Roberts, Linping Zhang, Filip Jankú et al. · Science Translational Medicine · 2014 · 368 citations · Full text

Asparaginase and MOPP Treatment of Dogs with Lymphoma

E. M. Brodsky, G.N. Maudlin, Joshua L. Lachowicz et al. · Journal of Veterinary Internal Medicine · 2009 · 72 citations · Full text

Mutations in the fifth immunoglobulin‐like domain of kit are common and potentially sensitive to imatinib mesylate in feline mast cell tumours

Mayu Isotani, Osamu Yamada, Joshua L. Lachowicz et al. · British Journal of Haematology · 2009 · 62 citations

Cancer Research, Immunogenetics, Signal Transduction +13

Phase II study of the oral selective inhibitor of nuclear export (SINE) KPT-335 (verdinexor) in dogs with lymphoma

Abbey R. Sadowski, Heather L. Gardner, Antonella Borgatti et al. · BMC Veterinary Research · 2018 · 44 citations · Full text